Hari Sankaran, M.D., M.Sc.

Dr. Sankaran has been a with the National Cancer Institute since 2019 and was appointed as a medical officer in 2020. He did his residency in Pediatrics in 2012 and fellowship in Pediatric Hematology-Oncology in 2015 at Baylor College of Medicine. During his fellowship, Dr. Sankaran also completed a Masters in Epidemiology at the University of Texas School of Public Health in 2016. His research interests include evaluating biomarkers in clinical trials, study design, survival analysis. Dr. Sankaran serves on the Core Correlative Science Committee and attends on the Pediatric Oncology Branch service in the Clinical Care Center. Dr. Sankaran also sits on the editorial board of the NCI PDQ Cancer Integrative, Alternative, and Complementary Therapies Editorial Board.